title: Continuous subcutaneous insulin infusion providing better glycemic control and quality of life in Type 2 diabetic subjects hospitalized for marked hyperglycemia.
authors.forename: I-Te
authors.initials: IT
authors.lastname: Lee
authors.forename: Yi-Ju
authors.initials: YJ
authors.lastname: Liau
authors.forename: Wen-Jane
authors.initials: WJ
authors.lastname: Lee
authors.forename: Chien-Ning
authors.initials: CN
authors.lastname: Huang
authors.forename: Wayne H-H
authors.initials: WH
authors.lastname: Sheu
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D055104:Infusions, Subcutaneous; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D011446:Prospective Studies; D011788:Quality of Life; D013624:Taiwan
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin